Cibus (NASDAQ:CBUS) Reports Q1 2026 Financial Results: Revenue Beat, EPS Miss

• Cibus (NASDAQ:CBUS) exceeded revenue expectations for the quarter, reporting $1.68 million against an estimated $1.61 million.
• The company's earnings per share (EPS) of -$0.33 missed analyst consensus of -$0.27, reflecting current unprofitability.
• Despite the EPS miss, Cibus demonstrated a strong current ratio of 2.37 and extended its cash runway, progressing towards product commercialization.

Cibus (NASDAQ:CBUS) is an agricultural technology (AgTech) company that focuses on developing innovative crop traits. It uses advanced breeding techniques to create products like herbicide-tolerant rice. Cibus works with global seed partners to bring its innovations to market, aiming to increase the speed and scale of advanced plant breeding.

On May 14, 2026, Cibus reported its quarterly financial results and performance. The company announced an earnings per share (EPS) of -$0.33. This figure represents the company's net loss divided by its number of shares. The announced EPS missed the analyst consensus estimate, which was a loss of -$0.27 per share.

Despite the earnings miss, Cibus posted quarterly revenue of $1.68 million for the quarter. This surpassed the estimated revenue figure of $1.61 million. This result also shows significant growth compared to the $1.03 million in revenue generated in the same quarter of the previous year.

The company's financial data shows a negative Price-to-Earnings (P/E) ratio of -9.06, which indicates it is not currently profitable. However, its current ratio of 2.37, a key liquidity indicator, suggests it has enough short-term assets to cover its short-term liabilities. This ratio is a key measure of a company's ability to pay its immediate debts.

As highlighted by MarketBeat, Cibus is moving closer to commercializing its key programs. Cibus also reduced expenses, extending its cash runway and financial stability into the first quarter of 2027. It recently raised approximately $37 million from public offerings to help convert its product pipeline commercialization into revenue.